Brigitte Poirier
Chercheuse associée
Axe Oncologie
Publications
Voir tout-
article Lemieux J, Côté I, Lemay M, Lauzier S, Després P, Desbiens C, Doyle C, Poirier B, Baghdadli A, Di Schiavi Trotta L, Nabi H
Development and Evaluation of a Web-Based App for Adverse Effect Management in Breast Cancer Patients Treated with Oral Targeted Therapy or Chemotherapy: Findings from a Pilot St…
Curr Oncol 33 (5), 2026.
-
article Nguyen Van Long F, Poirier B, Desbiens C, Perron M, Paquet C, Ouellet C, Diorio C, Lemieux J, Nabi H
Corrigendum to « First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers? » [Cancer Tre…
Cancer Treat Rev 143 2026.
-
article Gauthier V, Simard AJ, Desbiens C, Poirier B, Boudreau D, Leblanc D, Morin C, Hogue JC, Poirier É
Neoadjuvant chemotherapy in invasive lobular carcinoma of the breast: perspectives based on the survival outcomes
Front Oncol 15 2025.
Projets
- An Open-label, Randomized Phase 3 Study of MK-2870 as a Single Agent and in Combination with Pembrolizumab Versus Treatment of Physician’s Choice in Participants with HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer, du 2024-12-03 au 2030-12-25
- Vers une plateforme intégrée de soins et de recherche en oncologie (MediFirst GENETICS), du 2026-01-19 au 2027-03-31
- NSABP Breast Cancer Treatment Protocols, du 1997-02-01 au 2025-12-25
- Personalized risk-stratified breast cancer follow-up care: a feasibility and acceptability study, du 2023-06-26 au 2026-06-30